21 March 2005
Final Results for the 12 months ended 31 December 2004
Futura Medical plc, the pharmaceutical drug and medical device group that develops innovative products for the sexual healthcare market, announces its Final Results for the 12 months ended 31 December 2004.
Highlights
- MED2002 - exclusive discussions entered into with a major global pharmaceutical group for a proposed agreement for the worldwide development and marketing of MED2002
- CSD500 - extensive stability work undertaken and production trials scheduled
- FLD500 - encouraging safety and efficacy results from study completed in November 2004
- Pre-tax loss of £1.4 million for year ended 31 December 2004 (11 months ended 31 December 2003: £1.5 million)
- Cash balances of £3.7 million at 31 December 2004 (31 December 2003: £2.4 million)
Commenting on the results, James Barder, Chief Executive, said: "We continue to make solid progress with our product development and completing the development of our lead products remains our absolute priority."